We are live on !
Find out more
Roberts, Glore & Co Portfolio holdings
AUM
$416M
Turnover
9.34%
1-Year Est. Return
21.8%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+21.8%
3 Year Est. Return
+82.69%
5 Year Est. Return
+98.42%
10 Year Est. Return
+313.14%
AUM
$416M
AUM Growth
+$11.2M
(+2.8%)
Cap. Flow
+$3.72M
Cap. Flow % of AUM
Cap. Flow %
0.89%
Top 10 Holdings %
Top 10 Hldgs %
35.41%
Holding
257
New
11
Increased
126
Reduced
77
Closed
13
Avg Time Held
6.2
years
Top 10 Avg Time Held
5.6
years
Top 20 Avg Time Held
5.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$1.11M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$668K |
| 3 |
Abbott
ABT
|
+$650K |
| 4 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$628K |
| 5 |
Sprott Physical Gold and Silver Trust
CEF
|
+$468K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
U.S. Small Cap Value Portfolio ETF Class Shares
DFSV
|
+$2.74M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$655K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$490K |
| 4 |
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
|
+$434K |
| 5 |
Snowflake
SNOW
|
+$365K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.52% |
| 2 | Technology | 20.9% |
| 3 | Healthcare | 14.28% |
| 4 | Financials | 10.98% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Phillips 66
PSX
$103B
| $908K | 0.22% |
3,556
-250
| -7% | -$57.1K |
2013 Q2
53 quarters
|
|
102
Dell
DELL
$219B
| $883K | 0.21% |
1,642
-88
| -5% | -$41.3K |
2025 Q2
5 quarters
|
|
103
Merck
MRK
$364B
| $877K | 0.21% |
6,037
| – | – |
2013 Q2
53 quarters
|
|
104
eBay
EBAY
$53.1B
| $855K | 0.21% |
8,059
+618
| +8% | +$67.3K |
2013 Q2
53 quarters
|
|
105
Canadian National Railway
CNI
$76.3B
| $852K | 0.21% |
7,166
| – | – |
2013 Q2
53 quarters
|
|
106
Royce Micro-Cap Trust
RMT
$709M
| $831K | 0.2% |
61,844
+6,554
| +12% | +$91.2K |
2017 Q3
36 quarters
|
|
107
Nice
NICE
$5.51B
| $799K | 0.19% |
7,184
-1,195
| -14% | -$122K |
2024 Q3
8 quarters
|
|
108
Western Asset Inflation-Linked Income Fund
WIA
$177M
| $757K | 0.18% |
99,409
+2,585
| +3% | +$20.5K |
2016 Q1
42 quarters
|
|
109
Dimensional National Municipal Bond ETF
DFNM
$2.32B
| $754K | 0.18% |
16,385
-1,350
| -8% | -$64.1K |
2022 Q4
15 quarters
|
|
110
Interactive Brokers
IBKR
$37.1B
| $746K | 0.18% |
8,732
+735
| +9% | +$67.3K |
2026 Q2
1 quarter
|
|
111
Elevance Health
ELV
$92.8B
| $731K | 0.18% |
1,879
| – | – |
2020 Q4
23 quarters
|
|
112
Texas Pacific Land
TPL
$20.1B
| $719K | 0.17% |
2,206
+339
| +18% | +$128K |
2026 Q1
2 quarters
|
|
113
HCA Healthcare
HCA
$104B
| $718K | 0.17% |
1,683
+166
| +11% | +$68K |
2026 Q2
1 quarter
|
|
114
Blackrock
BLK
$189B
| $716K | 0.17% |
677
-12
| -2% | -$13.1K |
2019 Q1
30 quarters
|
|
115
Carrier Global
CARR
$44.3B
| $710K | 0.17% |
12,947
+425
| +3% | +$26.3K |
2020 Q3
24 quarters
|
|
116
Cboe Global Markets
CBOE
$39.2B
| $709K | 0.17% |
2,577
+296
| +13% | +$83.9K |
2021 Q2
21 quarters
|
|
117
Chevron
CVX
$429B
| $707K | 0.17% |
3,464
+100
| +3% | +$19.7K |
2016 Q2
41 quarters
|
|
118
Intuit
INTU
$91.3B
| $706K | 0.17% |
2,562
+121
| +5% | +$38K |
2013 Q2
53 quarters
|
|
119
C.H. Robinson
CHRW
$15.6B
| $695K | 0.17% |
4,698
-132
| -3% | -$21.5K |
2013 Q2
53 quarters
|
|
120
Coca-Cola Consolidated
COKE
$14.3B
| $694K | 0.17% |
3,666
+373
| +11% | +$70.3K |
2026 Q2
1 quarter
|
|
121
Biogen
BIIB
$37.5B
| $693K | 0.17% |
3,066
+65
| +2% | +$13.8K |
2013 Q2
53 quarters
|
|
122
Netflix
NFLX
$255B
| $668K | 0.16% |
9,595
+1,127
| +13% | +$84.7K |
2022 Q4
15 quarters
|
|
123
Ulta Beauty
ULTA
$28.2B
| $661K | 0.16% |
1,211
+123
| +11% | +$63.7K |
2025 Q3
4 quarters
|
|
124
Invesco QQQ Trust
QQQ
$467B
| $661K | 0.16% |
894
+230
| +35% | +$164K |
2021 Q3
20 quarters
|
|
125
Eli Lilly
LLY
$1.29T
| $657K | 0.16% |
568
-5
| -0.9% | -$5.9K |
2023 Q1
14 quarters
|
|
Similar funds
CIM
RA
TM
Roberts, Glore & Co's Q3 2026 Portfolio in Review
As of Q3 2026, Roberts, Glore & Co held 257 positions worth $416M, up 2.8% from $404M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Roberts, Glore & Co's Q3 2026 filing shows 11 new, 126 increased, 77 reduced and 13 closed positions. Its largest new stake was BWX Technologies: 2,610 shares worth $358K. The largest sale was U.S. Small Cap Value Portfolio ETF Class Shares, an estimated $2.74M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- Roberts, Glore & Co's largest Q3 2026 buy was BWX Technologies: 2,610 shares worth $358K.
- Roberts, Glore & Co added most to SpaceX in Q3 2026, an estimated $1.11M increase.
- Roberts, Glore & Co's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $490K.
- Roberts, Glore & Co fully exited U.S. Small Cap Value Portfolio ETF Class Shares in Q3 2026, selling an estimated $2.74M.
- Roberts, Glore & Co's ten largest holdings make up 35% of its $416M portfolio in Q3 2026.
- Roberts, Glore & Co opened 11 new positions and closed 13 in Q3 2026.
- Roberts, Glore & Co's portfolio value rose 2.8% quarter-over-quarter to $416M.
Based on Roberts, Glore & Co's 13F filing for Q3 2026, filed 13 Nov 2026.